Hangzhou Tian-Mu-Shan Stock Soars to Day High with 9.98% Gain

Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co., Ltd. has experienced significant activity today, with the stock rising by 9.98% as of June 18, 2026. The stock reached an intraday high of CNY 17.96, marking a notable performance against the backdrop of the China Shanghai Composite, which declined by 0.43% on the same day. Over the past week, Hangzhou Tian-Mu-Shan has shown a robust increase of 12.67%, outperforming the broader market index. However, its one-month performance reflects a decline of 5.77%, indicating some volatility in the short term. On a yearly basis, the stock has appreciated by 38.15%, significantly surpassing the China Shanghai Composite's gain of 20.71%. Despite these positive short-term trends, the company faces challenges in long-term growth, with a modest annual net sales growth rate of 1.15% over the past five years. The company's market capitalization stands at CNY 2,014 million, and it operates within the pharmaceuticals and biotechnology sector. Key financial metrics include a high P/E ratio of 273.00 and a debt-to-equity ratio of 2.08, highlighting the company's financial structure.